Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB06637
http://purl.obolibrary.org/obo/dinto_DB06637
|
|---|---|
| Preferred Name | dalfampridine |
| Synonyms |
C5H6N2
pyridin-4-amine
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | dalfampridine
|
|---|---|
| label | dalfampridine
|
| DBSynonym |
fampridine-sr
el-970
4-aminopyridine
4-ap
fampridine
|
| ATCCode | N07XX07
|
| Definition | Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010.
|
| has pharmacological target |
See more
See less
|
| type | |
| InChIKey | InChIKey=NUKYPUAOHBNCPY-UHFFFAOYSA-N
|
| is metabolised by | |
| blocks |
See more
See less
|
| AHFScode | 92:92
|
| Synonym |
C5H6N2
pyridin-4-amine
|
| xref |
ChEBI:34385
RxList:http://www.rxlist.com/ampyra-drug.htm
Drugs.com:http://www.drugs.com/ampyra.html
National Drug Code Directory:10144-427-60
Wikipedia:http://en.wikipedia.org/wiki/4-Aminopyridine
|
| CASRN | 504-24-5
|
| prefixIRI | obo2:dinto_DB06637
|
| SMILES | NC1=CC=NC=C1
|
| InChI | InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)
|
| DBBrand |
ampyra
fampyra
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |